Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vanda Pharmaceuticals Inc. (VNDA)  
$5.13 0.08 (1.58%) as of 4:30 Tue 5/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 61,398,000
Market Cap: 314.97(M)
Last Volume: 774,374 Avg Vol: 701,733
52 Week Range: $3.38 - $6.66
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  803
Guru Rank Value     : 1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 121,098 121,098 148,134 388,157
Total Sell Value $513,345 $513,345 $684,141 $2,735,436
Total People Sold 5 5 6 8
Total Sell Transactions 10 10 14 33
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 549
  Page 11 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Deerfield Special Situations Fund, L.p. Possible Member of 10% Group   –       –       •   2015-12-09 4 B $8.21 $6,397,966 I/I 775,382 976,842 1.5     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-09-10 4 S $12.73 $1,300,502 D/D (102,162) 816,781     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-09-10 4 OE $4.73 $698,271 D/D 147,626 918,943     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-09-09 4 S $12.51 $369,985 D/D (29,577) 771,317     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-09-09 4 OE $4.73 $202,193 D/D 42,747 800,894     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-05-22 4 S $10.36 $1,754,050 D/D (169,238) 758,147     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-05-22 4 OE $0.33 $119,099 D/D 359,815 927,385     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-05-21 4 S $10.33 $177,287 D/D (17,157) 567,570     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-05-21 4 OE $0.33 $11,852 D/D 35,806 584,727     -
   Deerfield International Master Fund, L.p. 10% Owner   –       –       •   2015-05-15 3 IO $0.00 $0 I/I 0 4,784,157     -
   Baroldi Paolo SVP & Chief Medical Officer   •       –      –    2015-03-10 4 S $10.54 $94,228 D/D (8,940) 30,545     -
   Baroldi Paolo SVP & Chief Medical Officer   •       –      –    2015-03-10 4 OE $0.00 $0 D/D 17,500 39,485     -
   Kelly James Patrick SVP, CFO, Sec & Treasurer   •       –      –    2015-03-10 4 S $10.53 $131,099 D/D (12,450) 53,304     -
   Kelly James Patrick SVP, CFO, Sec & Treasurer   •       –      –    2015-03-10 4 OE $0.00 $0 D/D 24,531 65,754     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-03-10 4 S $10.53 $230,607 D/D (21,900) 548,921     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-03-10 4 OE $0.00 $0 D/D 43,750 570,821     -
   Dugan Richard W Director   –       •      –    2015-03-09 4 S $10.69 $51,335 D/D (4,804) 5,770     -
   Dugan Richard W Director   –       •      –    2015-03-09 4 OE $4.73 $50,046 D/D 10,574 10,574     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-02-05 4 D $11.28 $281,402 D/D (24,947) 527,071     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2015-02-05 4 OE $0.03 $1,594 D/D 48,154 552,018     -
   Deerfield International Master Fund, L.p. 10% Owner   –       –       •   2014-12-23 3 IO $0.00 $0 I/I 0 3,977,773     -
   Deerfield Partners, Lp Possible Member of 10% Group   –       –       •   2014-12-23 4 B $14.23 $2,332,713 I/I 162,014 1,674,781 1.5     -
   Watkins Thomas Director   –       •      –    2014-03-14 4 S $17.66 $618,170 D/D (35,000) 0     -
   Watkins Thomas Director   –       •      –    2014-03-14 4 OE $9.40 $329,000 D/D 35,000 35,000     -
   Baroldi Paolo SVP & Chief Medical Officer   •       –      –    2014-02-18 4 D $13.46 $62,454 D/D (4,640) 21,985     -
  549 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 11 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us